[1] |
Fief CA,Hoang KG,Phipps SD,et al.Examining the impact of antimicrobial fluoroquinolones on human DNA topoisomerase IIα and IIβ[J].ACS Omega,2019,4(2):4049-4055.
|
[2] |
Hu W,Huang XS,Wu JF,et al.Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches[J].J Med Chem,2018,61(20):8947-8980.
|
[3] |
Bisacchi GS,Hale MR.A “double-edged” scaffold:antitumor power within the antibacterial quinolone[J].Curr Med Chem,2016,23(6):520-577.
|
[4] |
Jiang YL,Li K,Huang WL,et al.Synthesis and antitumor activity of 3-(benzylidene thiazolotriazolone)fluoroquinolones[J].J China Pharm Univ(中国药科大学学报),2018,49(6):671-675.
|
[5] |
Yang T,Wang XM,Wang R,et al.Synthesis and antitumor activity of pefloxacin C-3(rhodanine unsaturated ketone)amide derivatives[J].J China Pharm Univ(中国药科大学学报),2017,48(5):543-547.
|
[6] |
Jackson PA, Widen JC, Harki DA, et al. Covalent modifiers:a chemical perspective on the reactivity of α,β-unsaturated carbonyls with thiols via hetero-Michael addition reactions[J].J Med Chem,2017,60(3):839-885.
|
[7] |
Xiang Y,Chen C,Wang WM,et al.Rhodanine as a potent scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors[J].ACS Med Chem Lett,2018,9(4):359-364.
|
[8] |
Xie YS,Gao LZ,Yan Q,et al.Synthesis and antitumor activity of fluoroquinolone C-3 isosteres(VIII):s-triazole sulfide-one thiosemicarbazone derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2015,46(4):416-420.
|
[9] |
Brown FC,Bradsher CK,Bond SM,et al.Rhodanine derivatives[J].J Am Chem Soc,1951,73(5):2357-2359.
|
[10] |
Kondo H,Sakamoto F,Kawakami K,et al.Studies on prodrugs.7.Synthesis and antimicrobial activity of 3-formylquinolone derivatives[J].J Med Chem,1988,31(1):221-225.
|
[11] |
McFadyen JS,Stevens TS.A new method for the conversion of acids into aldehydes[J].J Chem Soc,1936,58:584-587.
|
[12] |
Chen LH,Xie L,Xie JX.Total synthesis of an analog of schizandrin[J].Acta Pharm Sin(药学学报),1991,26(1):20-24.
|